BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Priority Programs at AACR 2025

  April 24, 2025

   · 

  10 min read
• Press Releases

  West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend

  April 24, 2025

   · 

  13 min read
• Press Releases

  Dizal to Showcase Data in Hematologic Malignancies and Lung Cancer at ASCO 2025

  April 24, 2025

   · 

  7 min read
• Press Releases

  Merck Announces First-Quarter 2025 Financial Results

  April 24, 2025

   · 

  19 min read
• Press Releases

  Ligand to Report First Quarter 2025 Financial Results on May 8, 2025

  April 24, 2025

   · 

  2 min read
• Press Releases

  Bristol Myers Squibb Reports First Quarter Financial Results for 2025

  April 24, 2025

   · 

  19 min read
• Press Releases

  PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

  April 24, 2025

   · 

  11 min read
• Press Releases

  Novocure Reports First Quarter 2025 Financial Results

  April 24, 2025

   · 

  17 min read
• Press Releases

  NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

  April 24, 2025

   · 

  6 min read
• Press Releases

  Cullinan Therapeutics to Present Results from REZILIENT1, a Phase 1/2 Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy, at ASCO 2025

  April 24, 2025

   · 

  6 min read